Department of Health. Living well with dementia: a national dementia strategy. 2009. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/168220/dh_094051.pdf. Accessed 3 Sep 2014.
National Institute for Health and Clinical Excellence-Social Care Institute for Excellence (NICE-SCIE). Dementia: the NICE-SCIE guideline on supporting people with dementia and their carers in health and social care (updated). National clinical practice guideline 42. London: The British Psychological Society and the Royal College of Psychiatrists; 2011.
Maher AR, Maglione M, Bagley S, Suttorp M, Hu JH, Ewing B, Wang Z, Timmer M, Sultzer D, Shekelle PG. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. JAMA. 2011;306:1359–69.
Lee P, Gill S, Freedman M, Bronskill S, Hillmer M, Rochan P. Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review. BMJ. 2004;329:75–8.
Ballard C, Howard R. Neuroleptic drugs in dementia: benefits and harm. Nat Rev Neurosci. 2006;7:492–500.
Schneider LS, Dagerman K, Insel PS. Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry. 2006;14:191–210.
Ballard CG, Gautheir S, Cummings JL, Brodaty H, Grossberg GT, Robert P, Lyketsos CG. Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol. 2009;5:245–55.
Ballard CG, Waite J, Birks J. Atypical antipsychotics for aggression and psychosis in Alzheimer’s disease. Cochrane Database Syst Rev 2006;(1):CD003476.
Committee on Safety of Medicines. Atypical antipsychotic drugs and stroke: message from Professor Gordon Duff, chairman, (CEM/CMO/2004/1). London: Committee on Safety of Medicines; 2004.
Federal Drug Administration Public Health Advisory. Death with antipsychotics in elderly patients with behavioral disturbances. 2010. www.fda.gov/drugs/drugsafety/. Accessed 3 Sep 2014.
Schneider L, Dagerman K, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA. 2005;294:1934–43.
Rochon P, Normand S, Gomes T, Gill S, Anderson G, Melo M, Sykora K, Lipscombe L, Bell C, Gurwitz J. Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med. 2008;2008(168):676–83.
Banerjee S. The use of antipsychotic medication for people with dementia: time for action. London: Department of Health; 2009.
National Audit Office. Improving services and support for people with dementia. London: The Stationery Office; 2007.
Crugel M, Paton G, Singh P, Jeboda R, Treloar A. Antipsychotics in people with dementia: frequency of use and rationale for prescribing in a UK mental health service. Psychiatrist. 2012;36:165–9.
Barnes T, Banerjee S, Collins N, Treloar A, McIntyre S, Paton C. Antipsychotics in dementia: prevalence and quality of antipsychotic drug prescribing in UK mental health services. Br J Psychiatry. 2012;201:221–6.
Kales H, Kim H, Zivin K, Valenstein M, Seyfried L, Chiang C, Cunningham F, Schneider L, Blow F. Risk of mortality among individual antipsychotics in patients with dementia. Am J Psychiatry. 2012;169:71–9.
Huybrechts K, Gerhard T, Crystal S, Olfson M, Avorn J, Levin R, Lucas J, Schneeweiss S. Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population-based cohort study. BMJ. 2012;344:e977.
Musicco M, Palmer K, Russo A, Caltagirone C, Adorni F, Pettenati C, Bisanti L. Association between prescription of conventional or atypical antipsychotic drugs and mortality in older persons with Alzheimer’s disease. Dement Geriatr Cogn Disord. 2011;31:218–24.
Raivio MM, Laurila JV, Strandberg TE, Tilvis RS, Pitkälä KH. Neither atypical nor conventional antipsychotics increase mortality or hospital admissions among elderly patients with dementia: a 2-year prospective study. Am J Geriatr Psychiatry. 2007;15:416–24.
Simoni-Wastila L, Ryder PT, Qian J, Zuckerman IH, Shaffer T, Zhao L. Association of antipsychotic use with hospital events and mortality among medicare beneficiaries residing in long-term care facilities. Am J Geriatr Psychiatry. 2009;17:417–27.
Lopez OL, Becker JT, Chang Y-F, Sweet RA, Aizenstein H, Snitz B, Saxton J, McDade E, Kamboh MI, DeKosky ST, Reynolds CF III, Klunk WE. The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer’s disease. Am J Psychiatry. 2013;170:1051–8.
Sultana J, Chang C, Hayes R, Broadbent M, Stewart R, Corbett A, Ballard C. Associations between risk of mortality and atypical antipsychotic use in vascular dementia: a clinical cohort study. Int J Geriatr Psychiatry. 2014;29(12):12049–542.
Ford DV, Jones KH, Verplancke J-P, Lyons RA, John G, Brown G, Brooks C, Bodger O, Couch T, Leake K. The SAIL Databank: building a national architecture for e-health research and evaluation. BMC Health Serv Res. 2009;9:157.
Lyons RA, Jones KH, John G, Brooks CJ, Verplancke J-P, Ford DV, Brown G, Leake K. The SAIL databank: linking multiple health and social care datasets. BMC Med Inform Decis Mak. 2009;9:3–25.
Jones KH, Ford DV, Jones C, D’Silva R, Thompson S, Brooks CJ, Heaven ML, Thayer DS, McNerney CL, Lyons RA. A case study of the Secure Anonymous Information Linkage (SAIL) Gateway: a privacy protecting remote access system for health related research and evaluation. J Biomed Inform 2014;50:196–204.
QOF READ codes v27 for 2013/2014. http://www.pcc-cic.org.uk/article/qof-read-codes-v28. Accessed 28 Feb 2014.
Khan N, Perera R, Harper S, Rose P. Adaption and validation of the Charlson Index for READ/OXMIS coded database. BMC Family Pract 2010;11;1. http://www.biomedcentral.com/1471-2296/11/1.
Bottle A, Aylin P. Comorbidity scores for administrative data benefited from adaption to local coding and diagnostic practices. J Clin Epidemiol. 2011;64:1426–33.
Uddin M, Groenwold R, van Staa T, de Boer A, Belitse S, Hoes A, et al. Performance of prior event rate ration adjustment method in pharmacoepidemiology: a stimulation study. Pharmacoepidemiol Drug Saf. 2015;24:468–77.
Brophy S, Jones K, Rahman M, Zhou S-M, John A, Atkinson M, et al. Incidence of Campylobacter and Salmonella infections following first prescription for PPI: a cohort study using routine data. Am J Gastroenterol. 2013;108:1094–100.
Stata version 12. 2011. http://www.stata.com.
Gill S, Bronskill S, Normand S-LT, Anderson G, Sykora K, Lam K, et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med. 2007;146:775–86.
Health and Social Care Information Centre. National Dementia & Antipsychotic Prescribing Audit 2012. HSCIC, 2012.
Barber R, Donaldson T. Antipsychotic medication in Dementia—United Kingdom perspective. IPA Bulletin, International Psychogeriatric Association, June 8–10, 2010.
Colgate R, Davies K, Lambert H, Turner A. Controlling the confusion: using barrier analysis in the care home sector. Adv Psychiatr Treat. 2012;18:426–33.
Kleijer BC, van Marum RJ, Egberts AC, Jansen PA, Knol W, Heerdink ER. Risk of cerebrovascular events in elderly users of antipsychotics. J Psychopharmacol. 2009;23:909–14.
Reilly J, Ayis S, Ferrier I, Jones S, Thomas S. QTc interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet. 2000;355:1048–52.
Parker C, Coupland C, Hippisley-Cox J. Antipsychotic drugs and risks of venous thromboembolism: nested case-control study. BMJ. 2010;341:c4245.
Schmedt N, Garbe E. Antipsychotic drug use and the risk of venous thromboembolism in elderly patients with dementia. J Clin Psychopharmacol. 2013;33:753–8.
Hagg S, Spigset O. Antipsychotic induced venous thromboembolism. CNS Drugs. 2002;16:765–76.
Gerhard T, Huybrechts K, Olfson M, Schneeweiss S, Bobo W, Doraiswamy P, et al. Comparative mortality risks of antipsychotic medications in community-dwelling older adults. Br J Psychiatry. 2014;205:44–51.
Liperoti R, Onder G, Landi F, Lapane K, Mor V, Bernabei R, Gambassi G. All-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia: a retrospective cohort study. J Clin Psychiatry. 2009;70:1340–7.
Jackson J, Schneeweiss S, VanderWeele T, Blacker D. Quantifying the role of adverse events in the mortality difference between first and second-generation antipsychotics in older adults: systematic review and meta-synthesis. PLoS One. 2014;9(8):e105376. doi:10.1371/journal.pone.0105376.
Trifiro G, Sultana J, Spina E. Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies. Drug Saf. 2014;37(7):501–20.
Alzheimer’s Society. Wales dementia diagnosis rates 2015. https://www.alzheimers.org.uk/site/scripts/download_info.php?fileID=2797. Accessed 24 Nov 2016.
Khan N, Harrison S, Rose P. Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract. 2010;60:128–36.
Brown A, Kirichek O, Balkwill A, Reeves G, Beal V, Sudlow C, Gallacher J, Green J. Comparison of dementia recorded in routinely collected hospital admission data in England with dementia recorded in primary care. Emerg Themes Epidemiol. 2016;13:11. doi:10.1186/s12982-016-0053-z.
Young J, Inouye S. Delirium in older people. BMJ. 2007;334:842–6.
Othman F, Crooks C, Card T. Community acquired pneumonia incidence before and after proton pump inhibitor prescription: a population based study. BMJ. 2016;355:i5813. doi:10.1136/bmj.i5813.
Livingston G, Kelly L, Lewis-Holmes E, Baio G, Morris S, Patel N, et al. Non-pharmacological interventions for agitation in dementia: a systematic review of randomised controlled trials. Br J Psychiatry. 2014;205:436–42.
Kales H, Gitlin L, Lyketsos C. Assessment and management of behavioural and psychological symptoms in dementia. BMJ. 2015;350:h369.
Corbett A, Burns A, Ballard C. Don’t use antipsychotics routinely to treat agitation and aggression in people with dementia. BMJ. 2014;349:g6420.
American Psychiatric Association. Guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia. 2016. http://psychiatryonline.org/doi/pdf/10.1176/appi.books.9780890426807. Accessed 8 June 2016.